Get 20% lifetime commission for referring investors to digrin.com
here.
Definium Therapeutics, Inc. ( DFTX) - Key Metrics
DFTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.44 | -$0.48 | -$0.48 |
| 2026Q1 | $0 | -$0.71 | -$0.39 | -$0.39 |
| 2025Q4 | $0 | -$0.56 | -$0.47 | -$0.47 |
| 2025Q3 | $0 | -$0.78 | -$0.34 | -$0.34 |
| 2025Q2 | $0 | -$0.50 | -$0.35 | -$0.35 |
DFTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.17 |
| 2026Q1 | 0% | -6.65 |
| 2025Q4 | 0% | -6.56 |
| 2025Q3 | 0% | -3.78 |
| 2025Q2 | 0% | -3.25 |
DFTX
Price: $45.26
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.8 billion